AURA Aura Biosciences, Inc.
Nasdaq · SEC CIK 1501796 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $40.06M 14 sales by 7 insiders
- Filings on record
- 112 since 2021-10-29, latest 2026-09-01 17:28
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Matrix Capital Management Company, LP | 10% | — | $39.04M |
| de los Pinos Elisabet | See Remarks, Dir | — | $380.8K |
| Hopkins Janet Jill | Chief Medical Off | — | $196.0K |
| Plavsic Mark | CTO | — | $157.5K |
| Kilroy Conor | See Remarks | — | $143.4K |
| Gibney Anthony S | See Remarks | — | $82.3K |
| Elazzouzi Amy | SVP, Fin, PAO | — | $56.6K |
| Kratz Erica | Chief Reg, Quality Off | — | — |
| Abu-Absi Susan | COO | — | — |
| Bitetti Teresa Marie | Dir | — | — |
Transactions 111
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-01 17:28 | 2026-09-01 | AURA | Person Julie | CHRO | A - Grant | $0.00 | +107.6K | 107.6K | New | $0 |
| D | 2026-09-01 17:26 | 2026-09-01 | AURA | Kratz Erica | Chief Reg, Quality Off | A - Grant | $0.00 | +100.9K | 100.9K | New | $0 |
| D | 2026-09-01 17:24 | 2026-09-01 | AURA | Hopkins Janet Jill | Chief Medical Off | A - Grant | $0.00 | +58.9K | 380.2K | +18% | $0 |
| D | 2026-09-01 17:23 | 2026-09-01 | AURA | Elazzouzi Amy | SVP, Fin, PAO | A - Grant | $0.00 | +23.5K | 143.6K | +20% | $0 |
| D | 2026-09-01 17:21 | 2026-09-01 | AURA | Abu-Absi Susan | COO | A - Grant | $0.00 | +134.5K | 134.5K | New | $0 |
| D | 2026-07-08 16:11 | 2026-07-07 | AURA | Bender Jeremy | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
| 2026-07-01 16:35 | 2026-07-01 | AURA | Kilroy Conor | See Remarks | A - Grant | $0.00 | +14.9K | 232.7K | +7% | $0 | |
| 2026-06-16 16:30 | 2026-06-16 | AURA | Gibney Anthony S | See Remarks | S - Sale | $6.42 | -12.8K | 265.4K | -5% | -$82.3K | |
| D | 2026-06-15 16:31 | 2026-06-11 | AURA | Bitetti Teresa Marie | Dir | A - Grant | $0.00 | +15.0K | 36.0K | +71% | $0 |
| D | 2026-06-15 16:30 | 2026-06-11 | AURA | Srivastava Sapna | Dir | A - Grant | $0.00 | +15.0K | 38.5K | +64% | $0 |
| D | 2026-06-15 16:30 | 2026-06-11 | AURA | Johnson David Michael | Dir | A - Grant | $0.00 | +15.0K | 194.2K | +8% | $0 |
| D | 2026-06-15 16:30 | 2026-06-11 | AURA | Mattessich Antony C. | Dir | A - Grant | $0.00 | +15.0K | 38.5K | +64% | $0 |
| DM | 2026-05-19 16:59 | 2026-05-19 | AURA | Holles Natalie C. | See Remarks, Dir | A - Grant | $0.00 | +1.15M | 1.15M | New | $0 |
| I | 2026-05-11 16:16 | 2026-05-07 | AURA | Matrix Capital Management Company, LP | 10% | S - Sale | $5.64 | -6.92M | 0 | -100% | -$39.04M |
| 2026-04-16 18:49 | 2026-04-16 | AURA | Kilroy Conor | See Remarks | S - Sale | $7.02 | -11.7K | 217.8K | -5% | -$82.4K | |
| D | 2026-03-03 | 2026-03-02 | AURA | Elazzouzi Amy | SVP, Fin | A - Grant | $0.00 | +44.5K | 120.1K | +59% | $0 |
| D | 2026-03-03 | 2026-03-02 | AURA | Gibney Anthony S | See Remarks | A - Grant | $0.00 | +71.2K | 278.2K | +34% | $0 |
| D | 2026-03-03 | 2026-03-02 | AURA | Hopkins Janet Jill | Chief Medical Off | A - Grant | $0.00 | +89.1K | 321.3K | +38% | $0 |
| D | 2026-03-03 | 2026-03-02 | AURA | Plavsic Mark | CTO | A - Grant | $0.00 | +62.3K | 243.7K | +34% | $0 |
| D | 2026-03-03 | 2026-03-02 | AURA | de los Pinos Elisabet | See Remarks, Dir | A - Grant | $0.00 | +166.0K | 575.8K | +41% | $0 |
| D | 2026-03-03 | 2026-03-02 | AURA | Kilroy Conor | See Remarks | A - Grant | $0.00 | +62.3K | 229.6K | +37% | $0 |
| 2026-02-17 | 2026-02-17 | AURA | Plavsic Mark | CTO | S - Sale | $5.05 | -15.9K | 181.4K | -8% | -$80.2K | |
| 2026-02-17 | 2026-02-17 | AURA | Hopkins Janet Jill | Chief Medical Off | S - Sale | $5.06 | -20.4K | 232.3K | -8% | -$103.2K | |
| 2026-02-17 | 2026-02-17 | AURA | Elazzouzi Amy | SVP, Fin | S - Sale | $5.06 | -8,549 | 75.5K | -10% | -$43.3K | |
| 2026-02-17 | 2026-02-17 | AURA | Kilroy Conor | See Remarks | S - Sale | $5.05 | -12.1K | 167.2K | -7% | -$61.0K | |
| 2026-02-17 | 2026-02-17 | AURA | de los Pinos Elisabet | See Remarks, Dir | S - Sale | $5.06 | -47.6K | 409.8K | -10% | -$241.1K | |
| 2026-01-20 | 2026-01-20 | AURA | Elazzouzi Amy | SVP, Fin | S - Sale | $4.86 | -1,581 | 84.1K | -2% | -$7,684 | |
| 2026-01-20 | 2026-01-20 | AURA | de los Pinos Elisabet | See Remarks, Dir | S - Sale | $4.86 | -16.9K | 457.5K | -4% | -$82.3K | |
| 2025-11-17 | 2025-11-17 | AURA | Hopkins Janet Jill | Chief Medical Off | S - Sale | $5.42 | -17.1K | 252.7K | -6% | -$92.7K | |
| 2025-10-29 | 2025-10-29 | AURA | de los Pinos Elisabet | See Remarks, Dir | S - Sale | $6.35 | -9,049 | 474.4K | -2% | -$57.5K | |
| 2025-10-29 | 2025-10-29 | AURA | Elazzouzi Amy | SVP, Fin | S - Sale | $6.35 | -896 | 85.7K | -1% | -$5,690 | |
| 2025-10-16 | 2025-10-16 | AURA | Plavsic Mark | CTO | S - Sale | $6.35 | -12.2K | 197.3K | -6% | -$77.3K | |
| DM | 2025-08-18 | 2025-08-18 | AURA | Elazzouzi Amy | SVP, Fin | M - OptEx | $3.96 | +12.9K | 92.0K | +16% | +$51.1K |
| D | 2025-08-18 | 2025-08-18 | AURA | Elazzouzi Amy | SVP, Fin | S - Sale+OE | $6.70 | -7,722 | 86.6K | -8% | -$51.7K |
| D | 2025-06-18 | 2025-06-17 | AURA | Srivastava Sapna | Dir | A - Grant | $0.00 | +13.0K | 23.5K | +124% | $0 |
| D | 2025-06-18 | 2025-06-17 | AURA | Johnson David Michael | Dir | A - Grant | $0.00 | +13.0K | 179.2K | +8% | $0 |
| D | 2025-06-18 | 2025-06-17 | AURA | Mattessich Antony C. | Dir | A - Grant | $0.00 | +13.0K | 23.5K | +124% | $0 |
| D | 2025-06-04 | 2025-06-02 | AURA | Gibney Anthony S | See Remarks | A - Grant | $0.00 | +150.0K | 206.9K | +263% | $0 |
| D | 2025-06-04 | 2025-06-02 | AURA | de los Pinos Elisabet | See Remarks, Dir | M - OptEx | $5.07 | +10.9K | 493.4K | +2% | +$55.5K |
| D | 2025-06-04 | 2025-06-02 | AURA | de los Pinos Elisabet | See Remarks, Dir | F - Tax | $6.16 | -9,948 | 483.4K | -2% | -$61.3K |
| D | 2025-05-20 | 2025-05-16 | AURA | Gibney Anthony S | See Remarks | P - Purchase | $4.90 | +50.0K | 58.5K | +592% | +$245.0K |
| D | 2025-05-20 | 2025-05-16 | AURA | Gibney Anthony S | See Remarks | S - Sale | $5.15 | -1,519 | 56.9K | -3% | -$7,823 |
| D | 2025-05-20 | 2025-05-16 | AURA | Johnson David Michael | Dir | P - Purchase | $4.90 | +20.0K | 166.2K | +14% | +$98.0K |
| 2025-04-16 | 2025-04-16 | AURA | Kilroy Conor | See Remarks | S - Sale | $5.49 | -7,162 | 179.3K | -4% | -$39.3K | |
| 2025-04-16 | 2025-04-16 | AURA | Elazzouzi Amy | SVP, Fin | S - Sale | $5.49 | -897 | 81.4K | -1% | -$4,925 | |
| D | 2025-04-02 | 2025-03-31 | AURA | Bitetti Teresa Marie | Dir | A - Grant | $0.00 | +21.0K | 21.0K | New | $0 |
| 2025-02-18 | 2025-02-18 | AURA | Hopkins Janet Jill | Chief Medical Off | S - Sale | $7.75 | -2,534 | 269.8K | -0.9% | -$19.6K | |
| 2025-02-18 | 2025-02-18 | AURA | Plavsic Mark | CTO | S - Sale | $7.75 | -2,151 | 209.5K | -1% | -$16.7K | |
| 2025-02-18 | 2025-02-18 | AURA | de los Pinos Elisabet | See Remarks, Dir | S - Sale | $7.75 | -20.2K | 482.4K | -4% | -$156.7K | |
| 2025-02-18 | 2025-02-18 | AURA | Elazzouzi Amy | SVP, Fin | S - Sale | $7.75 | -1,404 | 82.3K | -2% | -$10.9K | |
| D | 2025-02-04 | 2025-02-03 | AURA | de los Pinos Elisabet | See Remarks, Dir | A - Grant | $0.00 | +194.3K | 502.7K | +63% | $0 |
| D | 2025-02-04 | 2025-02-03 | AURA | Kilroy Conor | See Remarks | A - Grant | $0.00 | +90.5K | 186.5K | +94% | $0 |
| D | 2025-02-04 | 2025-02-03 | AURA | Hopkins Janet Jill | Chief Medical Off | A - Grant | $0.00 | +120.6K | 272.3K | +80% | $0 |
| D | 2025-02-04 | 2025-02-03 | AURA | Plavsic Mark | CTO | A - Grant | $0.00 | +90.5K | 211.6K | +75% | $0 |
| D | 2025-02-04 | 2025-02-03 | AURA | Elazzouzi Amy | SVP, Fin | A - Grant | $0.00 | +45.2K | 83.7K | +118% | $0 |
| 2025-01-21 | 2025-01-21 | AURA | de los Pinos Elisabet | See Remarks, Dir | S - Sale | $7.67 | -16.0K | 304.7K | -5% | -$122.4K | |
| 2025-01-21 | 2025-01-21 | AURA | Elazzouzi Amy | VP, Fin | S - Sale | $7.67 | -1,001 | 38.4K | -3% | -$7,678 | |
| 2024-11-18 | 2024-11-18 | AURA | Hopkins Janet Jill | Chief Medical Off | S - Sale | $9.36 | -11.8K | 151.7K | -7% | -$110.7K | |
| 2024-10-29 | 2024-10-29 | AURA | Elazzouzi Amy | VP, Fin | S - Sale | $10.74 | -553 | 39.4K | -1% | -$5,939 | |
| 2024-10-29 | 2024-10-29 | AURA | de los Pinos Elisabet | See Remarks, Dir | S - Sale | $10.74 | -9,200 | 320.6K | -3% | -$98.8K | |
| DT | 2024-10-21 | 2024-10-18 | AURA | Feder Julie B | CFO | S - Sale+OE | $12.03 | -25.1K | 134.3K | -16% | -$302.3K |
| DMT | 2024-10-21 | 2024-10-18 | AURA | Feder Julie B | CFO | M - OptEx | $3.44 | +25.1K | 159.4K | +19% | +$86.5K |
| DT | 2024-10-18 | 2024-10-18 | AURA | de los Pinos Elisabet | See Remarks, Dir | M - OptEx | $2.74 | +25.0K | 354.8K | +8% | +$68.5K |
| DT | 2024-10-18 | 2024-10-18 | AURA | de los Pinos Elisabet | See Remarks, Dir | S - Sale+OE | $12.04 | -25.0K | 329.8K | -7% | -$300.9K |
| 2024-10-16 | 2024-10-16 | AURA | Plavsic Mark | CTO | S - Sale | $9.85 | -7,383 | 121.1K | -6% | -$72.7K | |
| D | 2024-10-01 | 2024-09-27 | AURA | de los Pinos Elisabet | See Remarks, Dir | M - OptEx | $5.76 | +5,474 | 329.8K | +2% | +$31.5K |
| D | 2024-06-24 | 2024-06-20 | AURA | Srivastava Sapna | Dir | A - Grant | $0.00 | +10.5K | 10.5K | New | $0 |
| D | 2024-06-24 | 2024-06-20 | AURA | Mattessich Antony C. | Dir | A - Grant | $0.00 | +10.5K | 10.5K | New | $0 |
| D | 2024-06-24 | 2024-06-20 | AURA | Johnson David Michael | Dir | A - Grant | $0.00 | +10.5K | 146.2K | +8% | $0 |
| D | 2024-04-04 | 2024-04-02 | AURA | Kilroy Conor | GC, Sec | A - Grant | $0.00 | +96.0K | 96.0K | New | $0 |
| D | 2024-02-02 | 2024-02-01 | AURA | de los Pinos Elisabet | See Remarks, Dir | A - Grant | $0.00 | +162.9K | 324.4K | +101% | $0 |
| D | 2024-02-02 | 2024-02-01 | AURA | Hopkins Janet Jill | Chief Medical Off | A - Grant | $0.00 | +28.5K | 163.5K | +21% | $0 |
| D | 2024-02-02 | 2024-02-01 | AURA | Feder Julie B | CFO | A - Grant | $0.00 | +71.3K | 134.3K | +113% | $0 |
| 2024-01-24 | 2024-01-23 | AURA | Feder Julie B | CFO | S - Sale | $7.64 | -6,609 | 63.0K | -9% | -$50.5K | |
| 2024-01-24 | 2024-01-23 | AURA | de los Pinos Elisabet | See Remarks, Dir | S - Sale | $7.64 | -15.9K | 161.4K | -9% | -$121.1K | |
| MI | 2023-11-09 | 2023-11-07+ | AURA | Johnson David Michael | Dir | P - Purchase | $7.19 | +114.0K | 75.0K | New | +$820.0K |
| M | 2023-11-09 | 2023-11-07+ | AURA | Johnson David Michael | Dir | P - Purchase | $7.18 | +85.6K | 126.1K | +212% | +$615.0K |
| I | 2023-11-09 | 2023-11-09 | AURA | Matrix Capital Management Company, LP | 10% | P - Purchase | $9.00 | +1.56M | 6.92M | +29% | +$14.04M |
| DT | 2023-11-07 | 2023-11-06 | AURA | Feder Julie B | CFO | S - Sale+OE | $12.07 | -3,900 | 69.6K | -5% | -$47.1K |
| DT | 2023-11-07 | 2023-11-06 | AURA | Feder Julie B | CFO | M - OptEx | $2.74 | +3,900 | 73.5K | +6% | +$10.7K |
| DT | 2023-11-07 | 2023-11-06 | AURA | de los Pinos Elisabet | See Remarks, Dir | S - Sale+OE | $12.03 | -7,449 | 177.3K | -4% | -$89.6K |
| DT | 2023-11-07 | 2023-11-06 | AURA | de los Pinos Elisabet | See Remarks, Dir | M - OptEx | $2.74 | +3,800 | 184.7K | +2% | +$10.4K |
| D | 2023-11-03 | 2023-11-01 | AURA | Hopkins Janet Jill | Chief Medical Off | A - Grant | $0.00 | +135.0K | 135.0K | New | $0 |
| 2023-11-01 | 2023-10-30 | AURA | de los Pinos Elisabet | See Remarks, Dir | S - Sale | $6.83 | -9,586 | 180.9K | -5% | -$65.5K | |
| 2023-11-01 | 2023-10-30 | AURA | Feder Julie B | CFO | S - Sale | $6.82 | -3,385 | 69.6K | -5% | -$23.1K | |
| M | 2023-10-05 | 2023-10-03+ | AURA | Johnson David Michael | Dir | P - Purchase | $8.38 | +20.1K | 50.1K | +67% | +$168.2K |
| D | 2023-01-23 | 2023-01-19 | AURA | de los Pinos Elisabet | See Remarks, Dir | A - Grant | $0.00 | +121.9K | 190.5K | +178% | $0 |
| D | 2023-01-23 | 2023-01-19 | AURA | De Rosch Mark | COO | A - Grant | $0.00 | +42.2K | 58.6K | +258% | $0 |
| D | 2023-01-23 | 2023-01-19 | AURA | Rich Cadmus | See Remarks | A - Grant | $0.00 | +34.1K | 58.7K | +139% | $0 |
| D | 2023-01-23 | 2023-01-19 | AURA | Feder Julie B | CFO | A - Grant | $0.00 | +48.8K | 73.0K | +201% | $0 |
| MI | 2023-01-09 | 2023-01-05+ | AURA | Johnson David Michael | Dir | P - Purchase | $10.41 | +2,000 | 17.1K | +13% | +$20.8K |
| MI | 2022-12-30 | 2022-12-28 | AURA | Johnson David Michael | Dir | P - Purchase | $9.75 | +4,000 | 17.0K | +31% | +$39.0K |
| MI | 2022-12-15 | 2022-12-01 | AURA | Johnson David Michael | Dir | P - Purchase | $12.37 | +10.0K | 15.0K | +200% | +$123.7K |
| I | 2022-12-07 | 2022-12-05 | AURA | Matrix Capital Management Company, LP | 10% | P - Purchase | $12.00 | +1.25M | 5.36M | +30% | +$15.00M |
| 2022-11-02 | 2022-10-31 | AURA | De Rosch Mark | COO | S - Sale | $12.46 | -1,115 | 16.4K | -6% | -$13.9K | |
| 2022-11-02 | 2022-10-31 | AURA | de los Pinos Elisabet | See Remarks, Dir | S - Sale | $12.46 | -5,706 | 68.7K | -8% | -$71.1K | |
| 2022-11-02 | 2022-10-31 | AURA | Rich Cadmus | See Remarks | S - Sale | $12.45 | -1,672 | 24.6K | -6% | -$20.8K | |
| 2022-11-02 | 2022-10-31 | AURA | Feder Julie B | CFO | S - Sale | $12.45 | -2,015 | 24.2K | -8% | -$25.1K | |
| MI | 2022-06-14 | 2022-06-10+ | AURA | Johnson David Michael | Dir | P - Purchase | $14.30 | +20.0K | 10.0K | New | +$286.1K |
| M | 2022-06-14 | 2022-06-10+ | AURA | Johnson David Michael | Dir | P - Purchase | $14.34 | +30.0K | 30.0K | New | +$430.2K |
Purchase Sale Sale after option exercise All abbreviations